Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

States Take Center Stage In Tackling Rx Drug Pricing

Jul 26 2018

• By Brenda Sandburg

State Law_484086778 _1200.jpg

Related Content

Maryland 'Price Gouging' Law's Loss In Court Could Derail Similar Legislation

Apr 17 2018

US FDA Extends Payor Communications Safe Harbor To Off-Label Uses

Jun 12 2018

CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor

Jun 14 2018

Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model

May 12 2018

REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'

May 18 2018

Drug Importation Can Be Triggered By 'Excessive' Price Increases; Now US FDA Has To Decide What That Means

Jul 20 2018

Nevada Price Transparency Regs Have Trade Secret Safeguards; Industry Drops Lawsuit

Jul 06 2018

Opioid Litigation: Drug Mfrs. Lose Bid To Limit Data Disclosure; First Trials Set For March

Jul 04 2018

US Senators Seek 'Clarity’ On Middlemen Obstructing List Price Reductions

Jul 04 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

PhRMA Sues To Block 'Unprecedented' California Price Reporting Law

Dec 12 2017

Related Companies

Pfizer Inc.

Additional Topics

United States Pricing Debate US State News Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window